Plain-English translation of NCT05606692 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
During surgery for ovarian cancer, doctors need to put you to sleep with anesthesia. This trial is testing whether using propofol (one type of anesthesia) leads to better long-term health outcomes compared to sevoflurane (another type of anesthesia). Researchers will follow your health for up to 3 years after surgery to see which medication may help you recover better.
While both anesthesia medications are safe and commonly used, doctors don't yet know if one type helps ovarian cancer patients have better long-term survival and quality of life than the other. This study aims to find out which medication may be better for your specific situation.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive one of the two anesthesia medications during your planned ovarian cancer surgery—the choice is made by the study, not by you. During surgery, doctors will carefully monitor your vital signs to keep you safely asleep. After surgery, the research team will track your recovery, any complications within the first month, and your overall health at 6 months, 1 year, and 3 years after surgery through medical appointments and records.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Taiwan